Granulocyte Colony Stimulating Factor clinical trials

Explore recruiting granulocyte colony stimulating factor clinical trials.

Recruiting granulocyte colony stimulating factor studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Granulocyte Colony Stimulating Factor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF).

Germany, Spain, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Patients with VEXAS Syndrome

Denmark, Finland, Sweden, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM14 in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Granulocyte Colony Stimulating Factor trials by city

Granulocyte Colony Stimulating Factor clinical trials

Recruiting granulocyte colony stimulating factor studies right now

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

Loratadine for the Prevention of G-CSF-related Bone Pain

Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy

G-CSF After Chemo-radiation in Patients With Glioblastoma

OH2 Oncolytic Viral Therapy in Solid Tumors

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Improving White Blood Cell Collection From Healthy Donors

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

Also recruiting in Europe

Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 and Granulocyte Colony-Stimulating Factor (G-CSF) (G-TAK) in subjects with severe alcoholic hepatitis (sAH) and acute-on-chronic liver failure (ACLF).

VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Patients with VEXAS Syndrome

Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM14 in Combination with Irinotecan in Pretreated Patients with Selected Advanced Solid Tumors

Granulocyte Colony Stimulating Factor trials by city

Other conditions